OBJECTIVE: To investigate whether absence of secondary hyperparathyroidism in the presence of hypovitaminosis D has altered bone turnover, fracture risk and mortality. DESIGN: A prospective cohort study. PATIENTS: A total of 1280 older men and women living in residential care facilities. MEASUREMENTS: We measured baseline serum 25-hydroxyvitamin D (25OHD), serum intact PTH, serum amino-terminal propeptide of type I collagen (PINP) and serum carboxy-terminal telopeptide of type I collagen (CTX-I). Deaths and fractures were recorded prospectively. RESULTS: Hypovitaminosis D (25OHD < 39 nmol/l) and absence of secondary hyperparathyroidism (PTH > 7.0 pmol/l) in the presence of hypovitaminosis D were common in this sample with a prevalence of 77.5% and 53.3%, respectively. In the presence of hypovitaminosis D, residents showing a hyperparathyroid response (n = 406) had significantly higher serum bone turnover markers than individuals with serum PTH levels < or = 7.0 pmol/l (termed 'low vitamin D, normal PTH', n = 463). After adjusting for risk factors, mortality was significantly higher in the secondary hyperparathyroidism group than in the 'low vitamin D, normal PTH' group [hazard ratio (HR) = 1.35, 95% confidence interval (CI) 1.12-1.64; P = 0.002]. All residents with serum PTH levels < or = 7.0 pmol/l (n = 603) were similar with regard to both bone turnover and mortality, independent of their actual vitamin D status. CONCLUSION: Absence of secondary hyperparathyroidism in the presence of hypovitaminosis D appears to be common in the frail elderly and is associated with longer survival, similar to that observed in vitamin D-replete elderly subjects.
OBJECTIVE: To investigate whether absence of secondary hyperparathyroidism in the presence of hypovitaminosis D has altered bone turnover, fracture risk and mortality. DESIGN: A prospective cohort study. PATIENTS: A total of 1280 older men and women living in residential care facilities. MEASUREMENTS: We measured baseline serum 25-hydroxyvitamin D (25OHD), serum intact PTH, serum amino-terminal propeptide of type I collagen (PINP) and serum carboxy-terminal telopeptide of type I collagen (CTX-I). Deaths and fractures were recorded prospectively. RESULTS:Hypovitaminosis D (25OHD < 39 nmol/l) and absence of secondary hyperparathyroidism (PTH > 7.0 pmol/l) in the presence of hypovitaminosis D were common in this sample with a prevalence of 77.5% and 53.3%, respectively. In the presence of hypovitaminosis D, residents showing a hyperparathyroid response (n = 406) had significantly higher serum bone turnover markers than individuals with serum PTH levels < or = 7.0 pmol/l (termed 'low vitamin D, normal PTH', n = 463). After adjusting for risk factors, mortality was significantly higher in the secondary hyperparathyroidism group than in the 'low vitamin D, normal PTH' group [hazard ratio (HR) = 1.35, 95% confidence interval (CI) 1.12-1.64; P = 0.002]. All residents with serum PTH levels < or = 7.0 pmol/l (n = 603) were similar with regard to both bone turnover and mortality, independent of their actual vitamin D status. CONCLUSION:Absence of secondary hyperparathyroidism in the presence of hypovitaminosis D appears to be common in the frail elderly and is associated with longer survival, similar to that observed in vitamin D-replete elderly subjects.
Authors: Megan A Evans; Hyun Ah Kim; T Michael De Silva; Thiruma V Arumugam; Andrew N Clarkson; Grant R Drummond; Graeme R Zosky; Brad Rs Broughton; Christopher G Sobey Journal: J Cereb Blood Flow Metab Date: 2017-08-23 Impact factor: 6.200
Authors: B B Yeap; S A P Chubb; L Flicker; K A McCaul; P R Ebeling; G J Hankey; J P Beilby; P E Norman Journal: Osteoporos Int Date: 2011-02-26 Impact factor: 4.507
Authors: Priya Nair; Paul Lee; Claire Reynolds; Nguyen Dinh Nguyen; John Myburgh; John A Eisman; Jacqueline R Center Journal: Intensive Care Med Date: 2012-10-13 Impact factor: 17.440
Authors: Stephen B Kritchevsky; Janet A Tooze; Rebecca H Neiberg; Gary G Schwartz; Dorothy B Hausman; Mary Ann Johnson; Douglas C Bauer; Jane A Cauley; M Kyla Shea; Peggy M Cawthon; Tamara B Harris; Susan M Rubin; Francis A Tylavsky; Denise K Houston Journal: J Clin Endocrinol Metab Date: 2012-08-31 Impact factor: 5.958
Authors: Lars Rejnmark; Alison Avenell; Tahir Masud; Frazer Anderson; Haakon E Meyer; Kerrie M Sanders; Kari Salovaara; Cyrus Cooper; Helen E Smith; Elizabeth T Jacobs; David Torgerson; Rebecca D Jackson; JoAnn E Manson; Kim Brixen; Leif Mosekilde; John A Robbins; Roger M Francis; Bo Abrahamsen Journal: J Clin Endocrinol Metab Date: 2012-05-17 Impact factor: 5.958